Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib for central sensitisation in knee osteoarthritis
2006-000395-32Phase 4Completed
- Sponsor
- King's College London
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of etoricoxib in knee osteoarthritis (OA), sponsored by King's College London. Primary endpoints: Reduction in central sensitisation of pain assessed by functional MRI and Pressure pain threshold. Started Feb 2006; status: completed.
02
Drugs
etoricoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-000395-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000395-32.